KarenSSlobodMD
Pediatric Infectious Disease • Memphis, TNAssociate Professor, Pediatrics, University of Tennessee Health Science Center College of Medicine
Are you Dr. Slobod?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 22 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
St. Jude Children's Research Hospital
332 N Lauderdale St., Ms 0515
Memphis, TN 38105Phone+1 901-495-3006Fax+1 901-495-3842- Is this information wrong?
Summary
- Dr. Karen Slobod, MD is a pediatric infectious disease specialist in Memphis, Tennessee. She is currently licensed to practice medicine in Tennessee. She is an Associate Professor at University of Tennessee Health Science Center College of Medicine.
Education & Training
University of TennesseeFellowship, Pediatric Infectious Diseases, 1989 - 1992
Montreal Children's HospitalPediatrics, 1986 - 1989
McGill University Faculty of MedicineClass of 1986
Certifications & Licensure
TN State Medical License 1993 - 2025
Clinical Trials
- Hydroxyurea in Treating Patients With Epstein-Barr Virus-Associated Primary CNS Lymphoma and AIDS Start of enrollment: 1996 Oct 01
- Safety of the EnvPro HIV Vaccine in Healthy Volunteers Start of enrollment: 2003 Aug 01
Publications & Presentations
PubMed
- 1 citationsInterim safety and immunogenicity of COVID-19 omicron BA.1 variant-containing vaccine in children in the USA: an open-label non-randomised phase 3 trial.Avika Dixit, Richard Bennett, Kashif Ali, Carl Griffin, Robert A Clifford, Mark Turner, Rosanne Poston, Kelly Hautzinger, Anne Yeakey, Bethany Girard, Wen Zhou, Weipin...> ;The Lancet. Infectious Diseases. 2024 Mar 19
- 17 citationsSafety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults.Felicia Scaggs Huang, David I. Bernstein, Karen S. Slobod, Allen Portner, Toru Takimoto, Charles J. Russell, Michael M Meagher, Bart G. Jones, Robert E. Sealy, Christo...> ;Human Vaccines & Immunotherapeutics. 2021 Feb 1
- 14 citationsSafety and Immunogenicity of a Second Dose of an Investigational Maternal Trivalent Group B Streptococcus Vaccine in Nonpregnant Women 4–6 Years After a First Dose: Re...Geert Leroux-Roels, Zourab Bebia, Cathy Maes, Annelies Aerssens, Fien De Boever, Luca Grassano, Giada Buffi, Immaculada Margarit, A. Karsten, Stephen Cho, Karen S. Slo...> ;Clinical Infectious Diseases. 2020 Jun 10
- Join now to see all
Press Mentions
GSK Hands CureVac $294M to Form mRNA Infectious Disease PactJuly 20th, 2020
Grant Support
- Clinical And Primate Paramyxovirus Vaccine EvaluationNational Institute Of Allergy And Infectious Diseases2004–2008
- Recombinant Sendai Virus As A Novel HIV Vaccine VectorNational Institute Of Allergy And Infectious Diseases2003–2004
- Clinical Evaluation Of A Multi-Envelope AIDS VaccineNational Institute Of Allergy And Infectious Diseases1999–2002
- Treatment Of EBV Lymphoma By Induction Of Episomal LossNational Cancer Institute1997
